Oral Pre-Exposure Prophylaxis - Questions and Answers
This document provides basic guidance to program managers interested in developing a PrEP implementation program.
The document covers the following:
- What is the current guidance?
- Who is PrEP for?
- Can PrEP bring HIV prevention to people “left behind”?
- What about people who are only at risk of acquiring HIV infection during certain periods?
- How does PrEP need to be taken?
- Didn’t some trials show effectiveness with fewer PrEP doses?
- How long does it take for PrEP to become effective in different types of tissue, and how long does this last?
- Is introducing PrEP leading to sexual behaviour that is less safe?
- Do third parties pose additional risk?
- Is PrEP safe?
- Can PrEP cause resistance to antiretroviral medicines?
- How can PrEP be delivered?
- How does PrEP fit within national HIV programmes?
- What authorization is needed to implement PrEP?
- Guidance for Providing Informed-Choice Counseling on Sexual Health for Women Interested in PrEP: Kenya and South Africa
- PrEP Communications Accelerator
- Joint WHO/ILO Guidelines on Post-Exposure Prophylaxis (PEP) to Prevent HIV Infection
- People Are Going off PrEP in the COVID-19 Era Because They’re Not Having Sex
- HIV-Related Stigma and Discrimination Toolkit
- Promoting the Health of Men who Have Sex with Men Worldwide: A Training Curriculum for Providers
- Voluntary Medical Male Circumcision (VMMC): Demand Creation Toolkit
- Engaging Men in HIV and AIDS at the Service Delivery Level
- Developing Marketing and Communications Strategies to Promote Demand and Uptake of PrEP
- Responding to the HIV-related Needs of MSM in Africa: Workshop Guide
March 25, 2019